- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06557317
In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes (BGW In-Person)
Examining the Preliminary Efficacy of an In-Person Lifestyle Intervention for Black Female Adolescent/Caregiver Dyads at Risk for Type 2 Diabetes Mellitus
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Enrolled adolescent/caregiver dyads will participate in the 12-week program. Each week, participants will engage in 2 activities: an in-person Wellness Session and an at-home cooking experience using ingredients provided at the Wellness Session.
The study will examine the pre-post difference in overall diet quality, dermal carotenoid levels, physical activity, body composition, and glycemic measures among at-risk black adolescent girls and their caregivers. Investigators hypothesize that after the program, participants' diets will be higher in quality than before.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tashara M Leak, PhD, RD
- Phone Number: 607-255-7664
- Email: tml226@cornell.edu
Study Locations
-
-
New York
-
Brooklyn, New York, United States, 11212
- Recruiting
- Brownsville Neighborhood Health Action Center
-
Contact:
- Elana Martins
- Phone Number: 718-312-6135
- Email: emartin8@health.nyc.gov
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria for adolescent participants:
- 12-18 years of age
- self-identify as Black or African American
- have obesity (>=95th percentile BMI)
Exclusion Criteria for adolescent participants:
- pregnant or within 3 months postpartum.
- participated in a formal weight management program within 6 months prior to study.
- currently taking medications or diagnosed with a condition known to influence metabolism, physical activity ability, or cognitive function.
- have previously undergone bariatric surgery.
- have type 2 diabetes.
- unable to speak English or have developmental conditions that interfere with ability to communicate.
Inclusion Criteria for caregiver participants:
- 18 years or older.
- proficiency in speaking English.
- live in the same household as the adolescent who will also be enrolled.
- prepares the majority (>50%) of meals in the household.
Exclusion Criteria for caregiver participants:
- pregnant or within 3 months postpartum.
- unable to speak English or have developmental conditions that interfere with ability to communicate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Adolescent/Caregiver Dyads
Adolescent/Caregiver dyads receive 12-week in-person lifestyle program consisting of a Wellness session, Dance Classes, and an at-home Cooking Experience.
|
Weekly for 12 weeks, adolescent/caregiver dyads will attend 1) an in-person Wellness Session (mindfulness, nutrition lesson, dance class, program reflection) (90 min/wk) and 2) a home cooking experience using ingredients provided at the Wellness Session (60 min/wk).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in diet quality of adolescent participants, as measured by the Healthy Eating Index Scores
Time Frame: Baseline, 12 weeks [end of study]
|
Scores are calculated from three 24-hour diet records, range from 0-100.
Higher score reflects that higher alignment between one's diet and dietary recommendations from the Dietary Guidelines for Americans.
|
Baseline, 12 weeks [end of study]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in dermal carotenoids level
Time Frame: Baseline, 12 weeks [end of study]
|
Scores are measured using the Veggie Meter device, range from 0-800.
Higher score acts as proxy for fruits and vegetables consumption.
|
Baseline, 12 weeks [end of study]
|
|
Change in percent time sedentary
Time Frame: Baseline, 12 weeks [end of study]
|
Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days.
Percent time spent on sedentary will be calculated.
|
Baseline, 12 weeks [end of study]
|
|
Change in percent time spent in light activity
Time Frame: Baseline, 12 weeks [end of study]
|
Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days.
Percent time spent in light activity will be calculated.
|
Baseline, 12 weeks [end of study]
|
|
Change in percent time spent in moderate to vigorous activity
Time Frame: Baseline, 12 weeks [end of study]
|
Accelerometry data will be collected from wrist accelerometers worn by participants for 7 days.
Percent time spent in moderate and vigorous activity will be calculated.
|
Baseline, 12 weeks [end of study]
|
|
Change in body mass index
Time Frame: Baseline, 12 weeks [end of study]
|
Height will be measured using a stadiometer to the nearest decimal point in cm.
Weight will be measured using a scale to the nearest decimal in kg.
Body mass index will be calculated using kg/m^2.
|
Baseline, 12 weeks [end of study]
|
|
Change in body fat percentage
Time Frame: Baseline, 12 weeks [end of study]
|
Body fat percentage will be measured using a scale to the nearest decimal.
|
Baseline, 12 weeks [end of study]
|
|
Change in waist circumference
Time Frame: Baseline, 12 weeks [end of study]
|
Waist circumference will be measured using a waist circumference tape to the nearest decimal in cm.
|
Baseline, 12 weeks [end of study]
|
|
Change in high blood pressure status
Time Frame: Baseline, 12 weeks [end of study]
|
Blood pressure will be measured using blood pressure monitors.
High blood pressure is considered as reading of >=120/80.
|
Baseline, 12 weeks [end of study]
|
|
Change in HbA1c
Time Frame: Baseline, 12 weeks [end of study]
|
HbA1c will be assessed through a blood draw.
|
Baseline, 12 weeks [end of study]
|
|
Change in lipid profile
Time Frame: Baseline, 12 weeks [end of study]
|
Total, high-density, low-density cholesterol, and triglycerides will be assessed through a blood draws.
|
Baseline, 12 weeks [end of study]
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tashara M Leak, PhD, RD, Cornell University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0148278
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism Disorders
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
RenJi HospitalGuangdong Provincial People's Hospital; Shanghai First Maternity and Infant... and other collaboratorsEnrolling by invitationPCOS | IVF Outcome | Glucose Metabolism DisorderChina
-
University of PlymouthRecruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
Purdue UniversityAlmond Board of CaliforniaActive, not recruitingGlucose Intolerance | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
Wake Forest University Health SciencesNot yet recruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
Clinical Trials on Black Girls for Wellness In-Person
-
Cornell UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Weill...CompletedObesity, Childhood | Type2DiabetesUnited States
-
University of CincinnatiCompletedStress | Depressive Symptoms | Health Behavior | Cardiovascular Risk Factor | Self EfficacyUnited States
-
University of Illinois at ChicagoNational Institute on Minority Health and Health Disparities (NIMHD); University...RecruitingHIV Infections | Sexual Behavior | Sexually Transmitted Infections (Not HIV or Hepatitis)United States
-
Fertility Centers of IllinoisRush University Medical Center; Pulling Down the Moon, Holistic HealthUnknownAnxiety | Infertility, FemaleUnited States
-
Johns Hopkins Bloomberg School of Public HealthVital StrategiesCompletedOpioid Use Disorder | Substance Use Disorders | Stigma, SocialUnited States
-
University of Alabama at BirminghamCompletedMultiple SclerosisUnited States
-
University of Missouri-ColumbiaUnited States Department of DefenseRecruitingAutism Spectrum Disorder | Insomnia ChronicUnited States
-
RANDdfusion IncCompleted
-
University of MinnesotaCompletedOverweight | ObeseUnited States
-
University of ArizonaCompletedSleep Initiation and Maintenance DisordersUnited States